Significance of age and comorbidity on treatment modality, treatment adherence, and prognosis in elderly ovarian cancer patients-Reference-Cited by-同舟云学术

Significance of age and comorbidity on treatment modality, treatment adherence, and prognosis in elderly ovarian cancer patients

Published:2012-11 Issue:2 Volume:127 Page:367-374
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Jørgensen Trine Lembrecht,Teiblum Sandra,Paludan Merete,Poulsen Laurids Østergaard,Jørgensen Anni Young Stensgård,Bruun Karin Herskind,Hallas Jesper,Herrstedt Jørn

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference34 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. NORDCAN: cancer incidence, mortality, prevalence and survival in the Nordic countries, version 5.1;Engholm,2012

3. Ovarian cancer in younger vs older women: a population-based analysis;Chan;Br J Cancer,2006

4. Epithelial ovarian carcinoma in younger vs older women: is age an independent prognostic factor? The Hellenic Oncology Cooperative Group experience;Pectasides;Int J Gynecol Cancer,2007

5. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study;Winter;J Clin Oncol,2007

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease;Annals of Oncology;2024-03

2. Pan-cancer analyses of the associations between 109 pre-existing conditions and cancer treatment patterns across 19 adult cancers;Scientific Reports;2024-01-03

3. Management of advanced epithelial ovarian cancer in the older patient: an age stratified cohort study of a gynaecological cancer centre in Southern England;European Journal of Gynaecological Oncology;2024

4. Low plasma PD-L1 levels, early tumor onset and absence of peritoneal carcinomatosis improve prognosis of women with advanced high-grade serous ovarian cancer;BMC Cancer;2023-05-13

5. Older age should not be a barrier to testing for somatic variants in homologous recombination DNA repair-related genes in patients with high-grade serous ovarian carcinoma;Translational Oncology;2023-05